These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15606690)

  • 1. Lifetime glycaemic exposure predicts reduced coronary vasoreactivity in Type 1 diabetic subjects.
    Sundell J; Janatuinen T; Rönnemaa T; Naum A; Laine H; Luotolahti M; Nuutila P; Raitakari OT; Knuuti J
    Diabet Med; 2005 Jan; 22(1):45-51. PubMed ID: 15606690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes.
    Sundell J; Janatuinen T; Rönnemaa T; Raitakari OT; Toikka J; Nuutila P; Knuuti J
    Diabetologia; 2004 Apr; 47(4):725-31. PubMed ID: 15298350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes.
    Sundell J; Rönnemaa T; Laine H; Raitakari OT; Luotolahti M; Nuutila P; Knuuti J
    Diabetologia; 2004 Nov; 47(11):1888-94. PubMed ID: 15565375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated Type I diabetes.
    Sundell J; Laine H; Nuutila P; Rönnemaa T; Luotolahti M; Raitakari O; Knuuti J
    Diabetologia; 2002 Jun; 45(6):775-82. PubMed ID: 12107720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both BMI and waist circumference are associated with coronary vasoreactivity in overweight and obese men.
    Sundell J; Raitakari OT; Viikari J; Kantola I; Nuutila P; Knuuti J
    Obes Facts; 2012; 5(5):693-9. PubMed ID: 23108372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between insulin resistance and reduced coronary vasoreactivity in healthy subjects.
    Sundell J; Luotolahti M
    Can J Cardiol; 2004 May; 20(7):691-5. PubMed ID: 15197421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.
    Di Carli MF; Janisse J; Grunberger G; Ager J
    J Am Coll Cardiol; 2003 Apr; 41(8):1387-93. PubMed ID: 12706936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global myocardial perfusion and diastolic function are impaired to a similar extent in patients with type 2 diabetes mellitus and in patients with coronary artery disease--evaluation by contrast echocardiography and pulsed tissue Doppler.
    Dounis V; Siegmund T; Hansen A; Jensen J; Schumm-Draeger PM; von Bibra H
    Diabetologia; 2006 Nov; 49(11):2729-40. PubMed ID: 17016696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary flow reserve is reduced in young men with IDDM.
    Pitkänen OP; Nuutila P; Raitakari OT; Rönnemaa T; Koskinen PJ; Iida H; Lehtimäki TJ; Laine HK; Takala T; Viikari JS; Knuuti J
    Diabetes; 1998 Feb; 47(2):248-54. PubMed ID: 9519721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
    Prince CT; Becker DJ; Costacou T; Miller RG; Orchard TJ
    Diabetologia; 2007 Nov; 50(11):2280-8. PubMed ID: 17768606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive family history of coronary artery disease is associated with reduced myocardial vasoreactivity in healthy men.
    Sundell J; Laine H; Raitakari OT; Luotolahti M; Nuutila P; Knuuti J
    Int J Cardiol; 2006 Oct; 112(3):289-94. PubMed ID: 16298443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic status influences the nature and severity of coronary artery disease.
    Berry C; Noble S; Grégoire JC; Ibrahim R; Levesquie S; Lavoie MA; L'Allier PL; Tardif JC
    Diabetologia; 2010 Apr; 53(4):652-8. PubMed ID: 20225394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes.
    Maahs DM; Nadeau K; Snell-Bergeon JK; Schauer I; Bergman B; West NA; Rewers M; Daniels SR; Ogden LG; Hamman RF; Dabelea D
    Diabet Med; 2011 Feb; 28(2):148-55. PubMed ID: 21219421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes.
    Matheus AS; Tibiriçá E; da Silva PB; de Fátima Bevilácqua da Matta M; Gomes MB
    Diabet Med; 2011 Oct; 28(10):1188-93. PubMed ID: 21658123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
    Gustavsson CG; Agardh CD
    Eur Heart J; 2004 Dec; 25(23):2120-4. PubMed ID: 15571827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between glycosylated hemoglobin A1c and coronary flow reserve in patients with Type 2 diabetes mellitus.
    Huang R; Abdelmoneim SS; Nhola LF; Basu R; Basu A; Mulvagh SL
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):445-53. PubMed ID: 25695762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts.
    Steine K; Larsen JR; Stugaard M; Berg TJ; Brekke M; Dahl-Jørgensen K
    Eur J Heart Fail; 2007 Oct; 9(10):1044-50. PubMed ID: 17719271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study.
    Valenzuela-Garcia LF; Matsuzawa Y; Sara JD; Kwon TG; Lennon RJ; Lerman LO; Ruiz-Salmeron RJ; Lerman A
    Cardiovasc Diabetol; 2015 Aug; 14():106. PubMed ID: 26268857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
    Lind M; Bounias I; Olsson M; Gudbjörnsdottir S; Svensson AM; Rosengren A
    Lancet; 2011 Jul; 378(9786):140-6. PubMed ID: 21705065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.